$SLBT up 202% and curling back up 👀 🔹 Brand-new Nasdaq biotech name catching serious momentum after its SPAC combination 📈 🔹 SL Science is focused on gamma

$SLBT up 202% and curling back up 👀 🔹 Brand-new Nasdaq biotech name catching serious momentum after its SPAC combination 📈 🔹 SL Science is focused on gamma delta T-cell and Armed-T immunotherapy for solid tumors 🧬 🔹 Transaction valued SL Bio at roughly $5.6B with PIPE funding to support develo…